GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » Common Stock

KAPA (Kairos Pharma) Common Stock : $0.01 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kairos Pharma Common Stock?

Kairos Pharma's quarterly common stock stayed the same from Mar. 2024 ($0.01 Mil) to Jun. 2024 ($0.01 Mil) but then increased from Jun. 2024 ($0.01 Mil) to Sep. 2024 ($0.01 Mil).

Kairos Pharma's annual common stock stayed the same from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.01 Mil) but then increased from Dec. 2022 ($0.01 Mil) to Dec. 2023 ($0.01 Mil).

Kairos Pharma Common Stock Historical Data

The historical data trend for Kairos Pharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kairos Pharma Common Stock Chart

Kairos Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Common Stock
0.19 0.01 0.01 0.01

Kairos Pharma Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Kairos Pharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Kairos Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » Common Stock
Comparable Companies
NERV AAGH BRTX BIXT SNSE AFMD BCDA NYMXF SPRB LPTX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
2355 Westwood Boulevard, 139, Los Angeles, CA, USA, 90064
Website
https://kairospharma.com
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.